299. 嚢胞性線維症
[臨床試験数:1,592,薬物数:1,539(DrugBank:255),標的遺伝子数:81,標的パスウェイ数:162

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03058068
(ClinicalTrials.gov)
December 20206/2/2017Human MesenchymAl Stem Cells Infusion in Patients With Cystic FibrosisA Phase I, Randomized and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis - HAPICystic FibrosisBiological: Allo-hMSCs;Biological: PlaceboJoshua M HareNULLWithdrawn20 Years45 YearsAll0Phase 1United States
2NCT02866721
(ClinicalTrials.gov)
August 20167/8/2016Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic FibrosisA Phase I, Single Center, Open Label, Single Dose, Dose Escalation Study Assessing the Safety and Tolerability of AllogeneiC MEsenchymAl Stem CEll Infusion in Adults With Cystic Fibrosis-CEASE CFCystic FibrosisBiological: Mesenchymal Stem CellsErica RoeschCase Western Reserve University;Cystic Fibrosis FoundationActive, not recruiting18 YearsN/AAll14Phase 1United States
3NCT02625246
(ClinicalTrials.gov)
February 4, 20164/12/2015Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis BronchiectasisA Phase I, Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell (hMSC) Infusion in Patients With Non-Cystic Fibrosis BronchiectasisBronchiectasisBiological: hMSCsMarilyn GlassbergNULLCompleted30 Years87 YearsAll6Phase 1United States